Neumega
Neumega (oprelvekin) is a medication used to prevent severely low platelet levels in adults receving a certain type of chemotherapy (anti-cancer medication). It's no longer available in the United States, because it was discontinued.
What is Neumega (oprelvekin)?
Drug facts
Common questions about Neumega (oprelvekin)
Neumega (oprelvekin) is a platelet growth factor used to prevent severely low platelet levels (thrombocytopenia) after receiving chemotherapy. Platelets help form blood clots to help you stop bleeding when you get injured. When you receive chemotherapy that causes your platelet levels to drop very low, you're at risk of serious bleeding. Neumega (oprelvekin) stimulates (turns on) cells in your bone marrow to make platelets so your levels don't get too low.
No, Neumega (oprelvekin) has been discontinued and is no longer available in the United States. It's not clear why the medication has been discontinued.
According to the National Comprehensive Cancer Network (NCCN) guidelines, Nplate (romiplostim) is currently used off-label to raise platelet levels in people who are receiving chemotherapy. Some studies also suggest that similar medications like Promacta (eltrombopag) may be helpful in certain situations. Speak to your provider about the best treatment options for you.
How to save using GoodRx
Neumega (oprelvekin) dosage
Typical dosage for Neumega (oprelvekin)
Interactions between Neumega (oprelvekin) and other drugs
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.